Product Description
The global intraoral scanner market was valued at over $1.1 billion in 2024. This is expected to increase over the forecast period at a CAGR of 9.9% to reach over $2.2 billion.
The full report suite on the global market for intraoral scanner analyzes intraoral scanners across different regions.
This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Market Drivers & Limiters
- Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL INTRAORAL SCANNER MARKET INSIGHTS
Artificial intelligence (AI) is also beginning to play a significant role in intraoral scanners, particularly in automating the process of capturing digital impressions. AI algorithms are being used to guide clinicians during the scanning process, ensuring that scans are both accurate and complete. In addition, AI-powered software can automatically detect anomalies, such as caries or misalignments, and highlight them for further attention. As AI continues to evolve, its integration into intraoral scanners is expected to enhance diagnostic capabilities and further streamline clinical workflows.
GLOBAL INTRAORAL SCANNER MARKET SHARE INSIGHTS
- Align Technology held the largest market share in the global intraoral scanner market, primarily due to its iTero™ product line, which has become the standard for digital scanning in orthodontics. The company’s dominance is driven by its seamless integration with Invisalign, providing practitioners with a comprehensive digital workflow for treatment planning and monitoring. The iTero™ lineup includes the iTero Element 5D, iTero Element 2 and iTero Lumina, with features such as near-infrared imaging (NIRI) for early caries detection, enhanced visualization, and AI-powered patient engagement tools. Align Technology continues to expand its global footprint by integrating its scanners into dental clinics and DSOs (Dental Service Organizations) worldwide, reinforcing its position as the industry leader.
- 3Shape was the second-leading company in the global intraoral scanner market. The company has been able to make strides in the market through ongoing innovations and product enhancements. Since introducing its first intraoral scanner, TRIOS, in 2011, 3Shape has continued to develop new scanners, releasing TRIOS 3 Mono in 2016, followed by TRIOS 3 in 2015. Notably from 2019, when it launched TRIOS 4, the company has consistently pursued advancements in its intraoral scanner technology. TRIOS 4 was the first intraoral scanner to offer the timely detection of both surface and interproximal caries. In addition to equipment, the company has continued to actively upgrade its software, recognizing its equal importance in driving device innovation. Its intraoral scanners have continued to gain popularity, and in 2022, 3Shape released an upgraded and wireless intraoral scanner, TRIOS 5.
- Envista Holdings ranked as the third-largest competitor in the global intraoral scanner market, leveraging its acquisition of Carestream Dental’s intraoral scanning business. This move, completed in 2022, brought the CS 3600, CS 3700 and CS 3800 intraoral scanners under its umbrella, rebranded under the DEXIS name. These scanners are widely recognized for their high-speed scanning capabilities, superior color capture and AI-powered precision. Envista has also focused on integrating its intraoral scanners with its Nobel Biocare implant planning and KaVo digital workflow solutions, making it a strong player in implantology and restorative dentistry. Additionally, Envista continues to expand its market reach by partnering with DSOs and offering bundled solutions that integrate imaging, diagnostics and treatment planning tools.
MARKET SEGMENTATION SUMMARY
- Intraoral Scanner Market
GLOBAL RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
